Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
pain drugs
Biotech
Biohaven pain spray aces test amid C-suite shake-up
Biohaven is eyeing filing for approval early next year for its experimental pain spray after data showed it hit its primary endpoints in a phase 3.
Ben Adams
Dec 6, 2021 10:00am
Non-opioid pain drug indirectly blocks a key ion channel
Nov 10, 2021 2:00pm
Potential pain remedy emerges from 'junkyard of cancer drugs'
Oct 27, 2021 9:52am
Biogen's non-opioid painkiller offers mixed results in phase 2
Sep 16, 2021 9:55am
Allay Therapeutics rakes in $60M for 'tunable' pain treatment
Sep 15, 2021 10:27am
Bone Therapeutics' lead program flops in knee osteoarthritis
Aug 30, 2021 9:45am